瞬时弹性成像技术在肝病诊断中的应用进展

doi:10.3969/j.issn.1672-5069.2016.01.002

Abstract

Yuan Pingge. Current perspectives on the application of transient elastography in diagnosis of liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 4-7.

[1] 肝脏硬度评估小组. 瞬时弹性成像技术诊断肝纤维化专家意见. 中华肝脏病杂志,2013,21（6）：420-424．
[2] Kemp W,Levy M,Weltman M. Australian Liver Association （ALA） expert consensus recommendations for the use of transient elastography in chronic viral hepatitis. J Gastroenterol Hepatol,2015,30（3）:453-462.
[3] European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines:Non-invasive tests for evaluation of liver disease severity and prognosis.J Hepatol,2015,63（1）:237-264.
[4] WHO Guidelines Approved by the Guidelines Review Committee.Guidelines for the screening,care and treatment of persons with hepatitis C infection. Geneva:World Health Organization,2014,Apr. [5] WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for the prevention,care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization,2015,Mar.
[6] Myers RP,Shaw H,Burak KW.An update on the management of chronic hepatitis C:2015 Consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol Hepatol,2015,29（1）:19-34.
[7] European Association for Study of Liver.EASL Clinical Practice Guidelines:management of hepatitis C virus infection.J Hepatol, 2014,60（2）:392-420.
[8] Sarri G,Westby M,Bermingham S,et al. Guideline Development Group. Diagnosis and management of chronic hepatitis B in children,young people,and adults:summary of NICE guidance.BMJ,2013,346:f3893.
[9] 纪冬,邵清,李冰,等 FibroScan对恩替卡韦治疗慢性乙型肝炎肝硬化的疗效评价. 传染病信息,2014,27（4）：213-215.
[10] Lim SG,Cho SW,Lee YC,et al. Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B. Hepatogastroenteroiogy,2011,58（106）:539-545.
[11] 马科,丁红方,黄加权,等.瞬时弹性扫描评估替比夫定治疗慢性乙型肝炎患者的疗效.胃肠病学和肝病学杂志,2015,24（9）:1130-1132.
[12] Singh S,Fujii LL,Murad MH,et al.Liver stiffness is associated with risk of decompensation, liver cancer,and death in patients with chronic liver diseases:a systematic review and meta-analysis. Clin Gastroenterol Hepatol,2013,11（12）:1573-1584.
[13] Lee HW,Yoo EJ,Kim BK,et al. Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy. Am Gastroenterol,2014,109（8):1241-1249.
[14] Sasso M,Beaugrand M,de Ledinghen V,et al. Controlled attenuation parameter （CAP）:a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol, 2010,36（11）:1825-1835.
[15] 沈峰,郑瑞丹,宓余强,等. 受控衰减参数诊断脂肪肝的临界值初探：一项多中心临床研究. 中华肝脏病杂志,2014,,22（12）：926-931.
[16] Nobili V,Vizzutti F,Arena U,et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology,2008,48（2）:442-448.
[17] de Franchis R,Baveno VI Faculty.Expanding consensus in portal hypertension:Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.J Hepatol,2015,63（3）:743-752.
[18] 李梵,闫涛,邵清,等. 肝硬化患者食管静脉曲张程度无创诊断的临床研究. 中华肝脏病杂志,2014,22（8）:600-603.
[19] 韩萍,纪冬,张健,等. 瞬时弹性成像检测对肝硬化腹水的预测作用研究. 解放军医学杂志,2011,36（11）:1143-1144.
[20] 刘芳,李隽,韩涛,等. 简易无创评分系统对乙型肝炎肝硬化患者食管静脉曲张出血的评估. 中华传染病杂志,2014,32（2）：111-115.
[21] Masuzaki R,Tateishi R,Yoshida H,et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology,2009,49（6）:1954-1961.
[22] Jung KS,Kim SU,Ahn SH,et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement （FibroScan）.Hepatology,2011,53（3）:885-894.
[23] Wong GL,Chan HL,Wong CK,et al. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. J Hepatol,2014,60（2）:339-345.
[24] Wang HM,Hung CH,Lu SN,et al. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients. Liver Int,2013,33（5）:756-761.
[25] 刘芳,李庭红,韩涛,等. 瞬时弹性成像在肝硬化门静脉高压中的临床评价. 中华肝脏病杂志,2013,2l（11）840-844.

Current perspectives on the application of transient elastography in diagnosis of liver diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[4]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[5]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[6]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[7]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Lu Lungen. Cholestatic liver diseases：What we know and how to deal with [J]. Journal of Practical Hepatology, 2019, 22(5): 754-757.
[10]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[11]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[12]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[13]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[14]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[15]	Zhang Junfei, Xu Heming, Song Haiyan, et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome:poor diagnostic sensitivity of Paris' criteria in Chinese patients [J]. Journal of Practical Hepatology, 2019, 22(4): 537-540.